$6.44
0.040.63%
Ult. Agg.: Oct 26, 4:06 PM
Lifecore Biomedical (LFCR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Lifecore Biomedical (LFCR) ha pubblicato l'ultima guidance il agosto 5, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $120M - $125M per il periodo.
Rispetto alle previsioni precedenti, Lifecore Biomedical ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Lifecore Biomedical ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Lifecore Biomedical. 7
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.21 | $-0.28 | — | $-0.30 |
| Actual | $-0.19 | $-0.43 | $-0.16 | $-0.29 |
| Surprise | +9.52% | -53.6% | — | +3.33% |
| Revenue | ||||
| Estimate | $32.1M | $26.3M | — | $26.6M |
| Actual | $34.2M | $23.2M | $35.7M | $31.1M |
| Surprise | +6.71% | -11.8% | — | +17.2% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.30 | $-0.10 | $-0.30 | $-0.22 |
| Revenue | ||||
| Consensus | $25.6M | $38.4M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-0.19 | $-0.21 | 9.52 % |
| Q1 | May 6, 2026 | $-0.43 | $-0.28 | -53.6 % |
| Q1 | Nov 6, 2025 | $-0.29 | $-0.30 | 3.33 % |
| Q4 | Aug 7, 2025 | $-0.06 | $-0.09 | 33.3 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $34.20M | $32.05M | 6.71 % |
| Q1 | May 6, 2026 | $23.19M | $26.30M | -11.8 % |
| Q1 | Nov 6, 2025 | $31.11M | $26.56M | 17.2 % |
| Q4 | Aug 7, 2025 | $36.44M | $35.52M | 2.61 % |